Cipla
Tapas Ranjan Nanda is a professional in market access and government sales within the pharmaceutical industry, currently serving as a Hospital Business Manager in Government Sales at Cipla since April 2023. Previously, Tapas worked as a Key Account Manager in Government Sales at Eli Lilly and Company from December 2018 to April 2023. Tapas holds a Bachelor of Pharmacy (BPharm) degree from Biju Patnaik University of Technology, Odisha, completed in 2018.
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.